Related Experiment Video
Updated: Aug 16, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Evaluation of the mannan antigen assay in neonates with or without Candida albicans colonization
Vasiliki Bourika1, Tania Siahanidou1, Kalliopi Theodoridou2
1Neonatal Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
Abstract:
Mannan antigen (MA) in neonates as a marker of invasive candidemia is not well studied, although 4% of all neonatal intensive care unit admissions are attributed to Candida spp. infections. The aim of this case-control study was to evaluate the performance of MA (Platelia™ Candida AgPluskit, Bio-Rad) in neonates who had rectal Candida colonization or in non-colonized controls. We cultured 340 rectal swabs of neonates and MA was negative in 24/25 C. albicans colonized (96% specificity) and in 30/30 non-colonized neonates (100% specificity). The results indicate a high specificity of the assay, which could be useful in neonates with possible candidemia.
Insights
Mannan antigen (MA) testing shows high specificity for detecting invasive candidemia in neonates. This diagnostic marker could aid in identifying serious Candida infections in high-risk infants.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Clinical Diagnostics
Background:
- Invasive candidemia is a serious concern in neonatal intensive care units (NICUs).
- Candida spp. infections affect 4% of NICU admissions.
- Mannan antigen (MA) as a marker for invasive candidemia in neonates is understudied.
Purpose of the Study:
- To evaluate the diagnostic performance of Mannan antigen (MA) testing.
- To assess MA's utility in neonates with rectal Candida colonization versus controls.
- To determine the specificity of the Platelia™ Candida AgPlus kit in a neonatal population.
Main Methods:
- A case-control study involving 340 neonates.
- Rectal swabs were cultured to identify Candida colonization.
- Mannan antigen (MA) levels were measured using the Platelia™ Candida AgPlus kit.
Main Results:
- MA testing demonstrated 96% specificity in neonates with *C. albicans* rectal colonization (24/25 positive).
- MA testing showed 100% specificity in non-colonized neonates (30/30 positive).
- The assay exhibited high specificity in the evaluated neonatal cohort.
Conclusions:
- Mannan antigen (MA) testing presents high specificity for diagnosing invasive candidemia in neonates.
- The Platelia™ Candida AgPlus kit shows potential as a valuable diagnostic tool.
- This assay could assist clinicians in identifying candidemia in neonates at risk.
More Related Videos
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
06:53Author Spotlight: Developing a Reproducible Method for Isolating Bone Marrow-Derived Macrophages from Neonatal Mice to Advance Early Life Immune Responses
Published on: May 24, 2024
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Candidiasis